Showing results (1361-1370 of 3,896) with videos related to

Sort By:
Pageof 390
Disease Markers|November 25, 2006
Expression of telomerase reverse transcriptase in psoriatic lesional skinMoushira A Mahmoud, Roshdy W Mohamed, Fadia M Attia, et al.
Disease Markers|February 1, 2007
Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parametersJong-Shiaw Jin, Chi-Ying Wu, Yeh-Feng Lin, et al.
Disease Markers|February 1, 2007
BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysisElias Zintzaras, Paraskevi Rodopoulou, George N Koukoulis
Disease Markers|February 1, 2007
Remarkable variation in the informativeness of RFLP markers linked to hemophilia B locus in Indian population groups: implication in the strategy for carrier detectionS Mukherjee, A Saha, Senthil Kumar P, et al.
Disease Markers|February 1, 2007
The frequency of cytochrome P450 2E1 polymorphisms in Black South AfricansPaul K Chelule, Rosemary J Pegoraro, Nceba Gqaleni, et al.
Disease Markers|September 1, 1990
Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. II. Intracellular detection of CD1 antigensM C Salamone, F R Roisman, A E Morelli, et al.
Disease Markers|May 28, 2005
Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in JapaneseYoshihiro Okamoto, Yoshimitsu Gotoh, Osamu Uemura, et al.
Disease Markers|May 3, 2007
Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populationsAntti-Pekka Laine, Hanna Holmberg, Anita Nilsson, et al.
Disease Markers|May 3, 2007
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutationsM Pedroni, B Roncari, S Maffei, et al.
Disease Markers|January 16, 2023
TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPPRongxin Shang, Jiakuan Chen, Yang Gao, et al.
Pageof 390